PHI with Terminal ileitis
How does this condition affect your private health insurance?
Ileitis terminalis refers to inflammation of the terminal ileum, the final section of the small intestine, typically a localized manifestation of Crohn's disease, a chronic inflammatory bowel disease. Symptoms include right lower quadrant abdominal pain, diarrhea, weight loss, and fever. It frequently leads to complications like strictures, fistulas, abscesses, and malabsorption. Its etiology involves genetic factors, immune dysregulation, and environmental triggers. Diagnosis relies on endoscopy, imaging, and biopsy. Treatment aims to manage inflammation, alleviate symptoms, prevent complications, and achieve remission, as it is a lifelong condition without a definitive cure.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 60%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months for an acute flare
Duration of Illness (Lifetime)
Chronic, lifelong condition with periods of remission and relapse
Cost of Treatment (Initial)
Thousands to tens of thousands of USD (including diagnostics, medications, potential hospitalization)
Cost of Treatment (Lifetime)
Hundreds of thousands to millions of USD (due to chronic medication, follow-ups, potential surgeries)
Mortality Rate
Low (less than 5%), usually due to severe complications like sepsis or post-surgical issues
Risk of Secondary Damages
High (>70%), including strictures, fistulas, abscesses, malabsorption, arthritis, skin conditions, and increased cancer risk
Probability of Full Recovery
Very low (<1%), as Crohn's disease is currently considered incurable; treatment aims for remission
Underlying Disease Risk
Moderate (15-30%) for associated extra-intestinal manifestations like arthritis, ankylosing spondylitis, primary sclerosing cholangitis, skin conditions, and eye inflammation. Genetic predispositions are common.